INmune Bio, Inc.
INMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $36 | $52 | $75 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $8 | $6 |
| Inventory | $0 | $0 | $0 | -$6 |
| Other Curr. Assets | $0 | $2 | $4 | $8 |
| Total Curr. Assets | $23 | $40 | $65 | $83 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $17 | $17 | $17 | $17 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $17 | $17 | $17 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $57 | $82 | $100 |
| Liabilities | – | – | – | – |
| Payables | $7 | $8 | $5 | $4 |
| Short-Term Debt | $0 | $10 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $1 | $1 | $0 | -$0 |
| Total Curr. Liab. | $7 | $18 | $11 | $4 |
| LT Debt | $0 | $0 | $10 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $0 |
| Total NC Liab. | $0 | $0 | $11 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $7 | $19 | $22 | $20 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $1 | $0 | $0 |
| Retained Earnings | -$163 | -$121 | -$91 | -$64 |
| AOCI | -$1 | -$1 | -$1 | $0 |
| Other Equity | $196 | $159 | $152 | $144 |
| Total Equity | $32 | $38 | $60 | $80 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $40 | $57 | $82 | $100 |
| Net Debt | -$21 | -$25 | -$37 | -$60 |